The goal for Crown’s Translational Medicine Division is to help our customers design the best clinical strategy for their drug candidates. By working with Crown and accessing its unique models and powerful molecular profiling and data analysis capabilities, our customers will significantly improve their probability of successful clinical development. More specifically, Crown will help its customers with:

• Clinical compound selection
• Clinical compound indication
• Biomarker strategies
• Patients stratification
• Clinical trial design

To achieve its goals, Crown has developed an impressive and unique collection of cancer models and assays. These can be used to select clinical candidate and better prepare for clinical development. The table below summarizes Crown Translational Profiling capabilities: